GENinCode secures additional £580,000 in fundraising
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Genincode PLC (GENIG)
Genincode PLC stock price live, this page displays LON GENIG stock exchange data. View the GENIG premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Genincode PLC real time stock price chart below.
What Is the Genincode PLC Stock Price Today?
The Genincode PLC stock price today is 0.88.
What Is the Stock Symbol for Genincode PLC?
The stock symbol for Genincode PLC is "GENIG."
What Stock Exchange Does Genincode PLC Trade On?
Genincode PLC is listed and trades on the London stock exchange.
Is Genincode PLC a Good Stock to Buy?
Determining whether Genincode PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GENIG quote. (ISIN: GB00BL97B504)
What Is the Genincode PLC Stock Price Today?
The Genincode PLC stock price today is 0.88.
What Is the Stock Symbol for Genincode PLC?
The stock symbol for Genincode PLC is "GENIG."
What Stock Exchange Does Genincode PLC Trade On?
Genincode PLC is listed and trades on the London stock exchange.
Is Genincode PLC a Good Stock to Buy?
Determining whether Genincode PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GENIG quote. (ISIN: GB00BL97B504)
London
Currency in GBP
0.88
-0.07(-7.37%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.85
1.00
52 wk Range
0.85
5.50
Trading near 52-week Low
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.851.00
52 wk Range
0.855.50
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
GENIG Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
7.50
Upside
+752.27%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- GENinCode raises £0.2 million through retail offer
- Investing.com
- GENinCode secures additional £580,000 in fundraising
- Investing.com
- GENinCode raises £0.2 million through retail offer
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 7.50
(+752.27% Upside)
Earnings
Latest Release
Jun 08, 2026
EPS / Forecast
-0.01 / --
Revenue / Forecast
1.47M / --
Compare GENIG to Peers and Sector
Metrics to compare | GENIG | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGENIGPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.2x | −0.4x | −0.5x | |
PEG Ratio | −0.06 | 0.00 | 0.00 | |
Price/Book | 53.4x | 1.0x | 2.6x | |
Price / LTM Sales | 2.2x | 0.5x | 3.0x | |
Upside (Analyst Target) | - | 45.5% | 58.6% | |
Fair Value Upside | Unlock | 29.8% | 10.2% | Unlock |
GENinCode Plc develops and commercializes clinical genetic tests to provide predictive analysis of risk to a patient’s health based on their genes in the United Kingdom and internationally. Its predictive technology offers patients and physicians with preventative care and treatment strategies. The company’s invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset. Its tests include Cardio inCode, a genetic test to help user to adopt cardiovascular prevention assesment; Lipid inCode, a genetic diagnostic test for familial hypercholesterolemia FH; SUDD inCode, genetic diagnostic test for familial heart diseases; Thrombo inCode, a genetic test for diagnosis of hereditary thrombophilia and the risk of thrombosis. In addition, the company offers Thrombo inCode Reproductive Health, is a genetic test that evaluates the impact of hereditary thrombophilia in patients with repeated miscarriages; and ROCA Test, a blood test that determines the risk of a woman having ovarian cancer. Further, it engages in the medical and scientific research activities. GENinCode Plc was incorporated in 2018 and is based in Manchester, the United Kingdom.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Genincode (GENIG) Stock Price Today?
The Genincode stock price today is 0.88 GBP.
What Stock Exchange Does Genincode Trade On?
Genincode is listed and trades on the London Stock Exchange.
What Is the Stock Symbol for Genincode?
The stock symbol for Genincode is "GENIG."
What Is the Genincode Market Cap?
As of today, Genincode market cap is 7.15M GBP.
What Is Genincode's Earnings Per Share (TTM)?
The Genincode EPS (TTM) is -0.02.
When Is the Next Genincode Earnings Date?
Genincode will release its next earnings report on Jun 08, 2026.
From a Technical Analysis Perspective, Is GENIG a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Genincode Stock Split?
Genincode has split 0 times.
How Many Employees Does Genincode Have?
Genincode has 44 employees.
What is the current trading status of Genincode (GENIG)?
As of Jun 16, 2026, Genincode (GENIG) is trading at a price of 0.88 GBP, with a previous close of 0.95 GBP. The stock has fluctuated within a day range of 0.85 GBP to 1.00 GBP, while its 52-week range spans from 0.85 GBP to 5.50 GBP.
What Is Genincode (GENIG) Price Target According to Analysts?
The average 12-month price target for Genincode is 7.50 GBP, with a high estimate of 7.5 GBP and a low estimate of 7.5 GBP. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +752.27% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.